Pancreatitis treatment depends heavily on whether the disease is acute or chronic, how severe it is, and what caused it. For a first episode of acute pancreatitis, the core approach has not changed dramatically in decades: aggressive intravenous fluids, pain control, and early feeding. What has changed is the evidence behind each of those steps and the growing toolkit for complications like infected necrosis, fluid collections, and the long-term damage that chronic pancreatitis inflicts on digestion and blood sugar regulation.
Fluid Resuscitation in the First Hours
The single most important intervention in early acute pancreatitis is intravenous fluid resuscitation. Inflammation of the pancreas causes fluid to leak from blood vessels into surrounding tissues, which can lead to low blood pressure, organ damage, and worsening inflammation if not corrected quickly. Hospitals typically start fluids within the first few hours of admission, aiming to restore circulating volume without overloading the heart or lungs.
The type of fluid matters. A systematic review and meta-analysis found that lactated Ringer’s solution reduced severity, mortality, the need for intensive care, organ failure, and local complications compared with normal saline, leading the authors to recommend it as the primary resuscitation fluid in early acute pancreatitis.1PubMed Central. Lactated Ringer’s Solution Reduces Severity, Mortality, Systemic and Local Complications in Acute Pancreatitis: A Systematic Review and Meta-Analysis A randomized trial comparing the two fluids directly showed that patients receiving lactated Ringer’s had dramatically lower markers of inflammation at 48 and 72 hours, and laboratory work suggested this was due to a direct anti-inflammatory effect of the lactate component itself.2PubMed Central. Fluid resuscitation with lactated Ringer’s solution vs normal saline in acute pancreatitis: A triple-blind, randomized, controlled trial Most current guidelines now favor lactated Ringer’s as the default choice.
Pain Control
Pain is often the dominant symptom of acute pancreatitis and one of the main reasons people seek emergency care. Adequate pain control is considered a primary treatment goal. Opioids have long been the go-to for severe pancreatic pain, but concerns about side effects, including the risk of dependence and potential effects on gut motility, have pushed researchers to evaluate non-opioid alternatives.3PubMed Central. Analgesia for the treatment of acute pancreatitis: a protocol for a systematic review and network meta-analysis Options under investigation include nonsteroidal anti-inflammatory drugs, acetaminophen, regional nerve blocks, and other analgesic strategies. In practice, most hospitals use a multimodal approach: starting with non-opioid medications and escalating to opioids when needed, rather than relying on opioids alone from the start.
For chronic pancreatitis, pain management is even more challenging because it may persist for years. Adjunctive treatments such as cognitive behavioral therapy delivered over the internet or by phone have shown moderate to large effects in reducing pain intensity and improving quality of life in pilot studies, suggesting that psychological interventions have a legitimate role alongside medications.4PubMed Central. Painful Chronic Pancreatitis – New approaches for evaluation and management
When and What to Eat
The old advice to keep patients fasting for days (“bowel rest”) has been overturned by evidence showing that early feeding is safer and may improve outcomes. Meta-analyses show that enteral nutrition, meaning food delivered through the gut rather than intravenously, significantly reduces the mortality rate of severe acute pancreatitis compared with intravenous (parenteral) feeding. To maintain the intestinal barrier and prevent bacteria from crossing into the bloodstream, feeding through the gut should ideally begin within the first 24 hours of hospital admission.5PubMed Central. Enteral nutrition in acute pancreatitis: a review of the current evidence
A Cochrane review comparing the two feeding approaches confirmed that enteral nutrition is feasible and showed trends toward reduced mortality, shorter hospital stays, and fewer infections, though the reduction in hospital stay was the only outcome that reached formal statistical significance at the time of the review.6Cochrane Database of Systematic Reviews. Total parenteral nutrition versus total enteral nutrition in acute pancreatitis In mild cases, patients can often resume a low-fat solid diet within a day or two. In severe cases, a feeding tube placed past the stomach may be necessary, but the principle remains the same: use the gut whenever possible.
Dealing with Gallstone-Related Pancreatitis
Gallstones are one of the most common triggers for acute pancreatitis. When a stone blocks the duct shared by the gallbladder and pancreas, digestive enzymes back up and damage pancreatic tissue. The definitive treatment is cholecystectomy, the surgical removal of the gallbladder, which is usually done during the same hospital admission for mild cases or shortly after recovery for severe ones.
In some patients, a stone remains stuck in the bile duct and causes an ongoing blockage or infection of the bile ducts (cholangitis). In that scenario, an emergency endoscopic procedure called ERCP is used to extract the stone. But when there is no cholangitis, the timing of ERCP is less clear-cut. A nationwide inpatient cohort study found no significant differences in mortality or complication rates between early and delayed ERCP in patients without cholangitis, though early ERCP was associated with shorter hospital stays and lower costs.7PubMed Central. Timing of endoscopic retrograde cholangiopancreatography in acute biliary pancreatitis without cholangitis: a nationwide inpatient cohort study In other words, rushing to ERCP does not save lives in the absence of active bile duct infection, but it may get patients home sooner.
Managing Infected Necrosis
In about a fifth of acute pancreatitis cases, portions of the pancreas or surrounding tissue die off, a condition called necrotizing pancreatitis. When that dead tissue becomes infected, typically a few weeks into the illness, the situation becomes life-threatening and requires intervention. The traditional approach was open surgery to physically remove the dead tissue (open necrosectomy), but this carried steep complication rates.
A landmark trial published in the New England Journal of Medicine compared open necrosectomy head-to-head with a “step-up” approach that began with percutaneous catheter drainage and escalated to minimally invasive surgery only if drainage alone failed. Major complications such as new-onset organ failure occurred in about 12% of patients in the step-up group compared with 40% in the open surgery group. Death rates were similar between groups, meaning the less aggressive approach was not undertreating the infection. About a third of step-up patients never needed surgery at all, getting by on drainage alone. The step-up group also developed fewer long-term problems like incisional hernias and new-onset diabetes.8PubMed. A step-up approach or open necrosectomy for necrotizing pancreatitis
A later trial, the TENSION trial, asked whether endoscopic drainage through the stomach wall was superior to the surgical step-up pathway. Major complications or death occurred at similar rates in both groups, roughly 43% for endoscopy and 45% for surgery, with no significant difference in mortality.9The Lancet. Endoscopic transluminal step-up approach versus minimally invasive surgical step-up approach in patients with infected necrotising pancreatitis (TENSION trial) The practical takeaway is that the step-up philosophy itself is what matters most; whether the initial drainage is done through the skin or through an endoscope depends on local expertise and the location of the necrosis.
Pseudocysts and Fluid Collections
After an episode of pancreatitis, fluid can accumulate around the pancreas and become walled off by a fibrous capsule over several weeks, forming what is called a pseudocyst. In many patients, these collections resolve on their own without any treatment. Drainage is only indicated when a pseudocyst or walled-off necrosis causes symptoms such as pain, nausea, or compression of nearby structures like the bile duct.10PubMed Central. Lumen apposing metal stents for pancreatic fluid collections: Recognition and management of complications
When drainage is needed, endoscopic techniques have become the preferred approach. A newer tool called a lumen-apposing metal stent creates a wide channel between the collection and the stomach or small intestine, allowing the fluid and debris to drain internally. This approach avoids external drains and open surgery in the majority of patients, though it requires a center with endoscopic expertise.
Vascular Complications and Why They Matter
Pancreatitis can affect the blood vessels that sit directly behind and alongside the pancreas. The splenic vein, portal vein, and mesenteric veins all run through the neighborhood of pancreatic inflammation, and severe disease can cause clots to form in these vessels. Splenic vein thrombosis is particularly associated with pseudocysts and severe necrotizing pancreatitis; it can lead to localized high pressure in the veins around the stomach and spleen, which in turn causes varices that may bleed.11Korean Journal of Radiology. Vascular Complications of Pancreatitis: Role of Interventional Therapy Bleeding from a pseudoaneurysm, where an inflamed artery wall weakens and balloons, is another feared complication that may require urgent treatment with angiographic embolization. These vascular problems are relatively uncommon, but recognizing them quickly is critical because they can become surgical emergencies.
Hypertriglyceridemia-Induced Pancreatitis
When very high blood triglyceride levels trigger pancreatitis, the triglycerides themselves need to be brought down quickly in addition to the standard supportive care. Two main options exist: insulin infusions, which activate an enzyme that breaks down triglycerides in the blood, and plasmapheresis, which physically filters triglyceride-rich particles out of the bloodstream.
The evidence comparing these two approaches is still limited, but what exists suggests they perform similarly for most patients. One review of controlled studies found that plasmapheresis lowered triglycerides somewhat faster (about 70% reduction within 24 hours versus roughly 50% with conservative treatment including insulin), but this speed advantage did not clearly translate into better clinical outcomes.12PubMed Central. The role of apheresis and insulin therapy in hypertriglyceridemic acute pancreatitis-a concise review A systematic review and meta-analysis found that insulin with or without heparin was at least comparable to plasmapheresis in reducing triglyceride levels, and the insulin group had a numerically lower mortality rate, though neither finding reached statistical significance.13PubMed Central. Efficacy and adverse effects of insulin versus plasmapheresis in patients with hypertriglyceridemia-induced acute pancreatitis: a systematic review and meta-analysis Another review of 34 cases concluded that insulin therapy with close glucose monitoring is safe and can serve as a practical first-line approach, especially at hospitals without access to plasmapheresis equipment.14PubMed Central. Hypertriglyceridemic Pancreatitis Treated with Insulin Therapy: A Comparative Review of 34 Cases The emerging consensus is to use insulin for mild cases and reserve plasmapheresis for severe episodes or situations where triglycerides are not falling fast enough.
Autoimmune Pancreatitis
Autoimmune pancreatitis stands apart from other forms because it responds to corticosteroids rather than the supportive measures used for typical pancreatitis. Most patients improve dramatically with a course of oral steroids. The harder question is what happens after the initial course ends, because relapses are common. A large Japanese multicenter study of 510 patients found that low-dose maintenance steroid therapy at 5 mg per day or higher cut the relapse rate to about 26%, compared with roughly 45% in patients who stopped steroids entirely.15PubMed. Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients The trade-off involves the well-known side effects of long-term steroid use, so the decision to continue maintenance therapy is individualized based on how likely a patient is to relapse.
Enzyme Replacement for Chronic Pancreatitis
As chronic pancreatitis progressively damages the pancreas, the organ loses its ability to produce enough digestive enzymes. This leads to malabsorption of fats and other nutrients, causing oily diarrhea, weight loss, and deficiencies in fat-soluble vitamins. Pancreatic enzyme replacement therapy (PERT) is the standard treatment and is considered both safe and effective.16PubMed Central. Pancreatic Enzyme Replacement Therapy: A Concise Review
A systematic review and meta-analysis confirmed that enzyme replacement significantly improved fat absorption, reduced stool fat and weight, and also decreased abdominal pain, all without significant side effects.17Gut. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis Despite the clear evidence, a cross-sectional study found that a quarter of patients with documented enzyme insufficiency were not taking enzymes at all, and another 20% were undertreated with doses below what guidelines recommend.18PubMed Central. Pancreatic enzyme treatment in chronic pancreatitis: Quality of management and adherence to guidelines–A cross‐sectional observational study Enzymes need to be taken with every meal and snack, the dose needs to match the amount of food eaten, and they should be swallowed during the meal rather than before or after. Getting this right makes a meaningful difference in symptoms and nutritional status.
Surgery for Chronic Pancreatitis Pain
Up to half of patients with chronic pancreatitis eventually need surgery because pain becomes unmanageable with medications and endoscopic procedures alone.19PubMed Central. Frey procedure for chronic pancreatitis: A narrative review The choice of procedure depends on the anatomy: whether the pancreatic duct is dilated, whether there is an inflammatory mass in the head of the pancreas, and whether there is a blockage in the bile duct.
The Frey procedure, which combines coring out the diseased head of the pancreas with opening up the main pancreatic duct to improve drainage, is one of the more commonly used operations. In one surgical series, about 78% of patients had complete or partial pain relief during follow-up, and several patients were able to stop or reduce opioid use.20JAMA Surgery. The Frey Procedure for Chronic Pancreatitis Secondary to Pancreas Divisum Other surgical options include the Whipple procedure for disease concentrated in the head of the pancreas and lateral pancreaticojejunostomy (a drainage operation) when the duct is widely dilated.
Total Pancreatectomy with Islet Autotransplantation
When chronic pancreatitis has destroyed quality of life and no lesser operation is expected to help, the most radical option is removing the entire pancreas. The obvious problem is that this guarantees diabetes, since the insulin-producing islet cells are removed along with the rest of the organ. Total pancreatectomy with islet autotransplantation (TPIAT) addresses this by isolating the patient’s own islet cells from the removed pancreas and infusing them into the liver, where they can engraft and continue producing insulin.
A single-center series spanning more than 30 years found that TPIAT preserved meaningful islet function in most patients, with about a quarter of adults and half of children achieving full insulin independence. Pain improved substantially even in patients who continued needing some pain medication.21PubMed Central. Total pancreatectomy and islet autotransplantation for chronic pancreatitis A prospective evaluation showed that opioid use dropped from about 61% of patients before surgery to 24% at one year, and daily abdominal pain fell from 65% to 23%.22Gastroenterology. Prospective Evaluation of Total Pancreatectomy With Islet Autotransplantation for Treatment of Chronic and Recurrent Acute Pancreatitis A smaller series using a laparoscopic approach reported that 90% of patients had decreased or resolved pain, and 60% stopped opioids entirely within six months.23JAMA Surgery. Laparoscopic Total Pancreatectomy With Islet Autotransplantation and Intraoperative Islet Separation as a Treatment for Patients With Chronic Pancreatitis TPIAT is available only at specialized centers and is typically reserved for patients who have exhausted other options, but for the right candidate it can be transformative.
Managing Pancreatogenic Diabetes
When chronic pancreatitis damages enough of the pancreas to cause diabetes, the resulting condition, sometimes called type 3c diabetes, behaves differently from the more common type 1 and type 2 forms. The loss of glucagon-producing cells alongside insulin-producing cells makes blood sugar more brittle and harder to control, and the coexisting malabsorption complicates matters further. Managing exocrine insufficiency with enzyme replacement, screening for fat-soluble vitamin deficiencies (especially vitamin D), and restoring normal fat digestion are all essential parts of the treatment plan.24PubMed Central. Diagnosis and treatment of diabetes mellitus in chronic pancreatitis
For blood sugar control, expert recommendations suggest starting with metformin as first-line therapy and avoiding insulin secretagogues when possible, adding insulin only when metformin alone cannot achieve adequate control.25Pancreatology. Pancreatogenic Diabetes: Special Considerations for Management This form of diabetes remains underdiagnosed and lacks official consensus guidelines of its own, which means patients are sometimes managed identically to type 2 diabetics without accounting for the unique risks of hypoglycemia and malnutrition that come with a damaged pancreas.26PubMed Central. Management of pancreatogenic diabetes: challenges and solutions
Alcohol and Smoking Cessation
For alcohol-related pancreatitis, quitting drinking is arguably the most effective treatment of all. A study following patients after a first episode of acute alcoholic pancreatitis found that none of the 18 patients who remained abstinent had a recurrence during a mean follow-up of about five years. Among the 100 patients who continued drinking, 34% had at least one recurrence.27Alcohol and Alcoholism. Abstinence after First Acute Alcohol-Associated Pancreatitis Protects Against Recurrent Pancreatitis and Minimizes the Risk of Pancreatic Dysfunction Separate research comparing patients who quit drinking with those who continued found that former drinkers had roughly half the rate of exocrine insufficiency (29% versus 59%), fewer pseudocysts, and were far more often relapse-free (37% versus 5%). Quitting smoking added a smaller but still measurable benefit.28PubMed. Impact of alcohol and smoking cessation on the course of chronic pancreatitis
Despite these striking numbers, structured cessation programs specifically designed for pancreatitis patients are uncommon. An ongoing randomized trial is testing whether a combined education and cessation program targeting both alcohol and cigarettes can prevent recurrent acute pancreatitis.29PubMed Central. Recurrent acute pancreatitis prevention by the elimination of alcohol and cigarette smoking (REAPPEAR): protocol of a randomised controlled trial and a cohort study Until results are available, the evidence strongly supports cessation counseling as a core part of treatment for anyone whose pancreatitis is linked to alcohol or tobacco.
Pharmacological Treatments Under Investigation
Several drug classes have been studied for acute pancreatitis beyond the standard supportive care, with mixed results. Protease inhibitors, which aim to neutralize the digestive enzymes damaging the pancreas, have been tested in numerous trials. A systematic review and meta-analysis of 17 trials found no significant reduction in mortality from intravenous protease inhibitors, and the authors concluded there is no solid evidence supporting their routine use.30PubMed Central. Treatment of acute pancreatitis with protease inhibitors administered through intravenous infusion: an updated systematic review and meta-analysis
One exception may be ulinastatin, a urinary trypsin inhibitor used more commonly in East Asian countries. A meta-analysis of seven studies in severe acute pancreatitis found a significant reduction in mortality risk with ulinastatin treatment, along with improvements in inflammatory markers and faster resolution of abdominal pain.31PubMed Central. Ulinastatin for the treatment of severe acute pancreatitis: a systematic review and meta-analysis When ulinastatin was combined with somatostatin (a hormone that suppresses pancreatic secretion), a separate meta-analysis of randomized trials reported roughly 70% reductions in rates of acute respiratory distress syndrome and kidney injury, and about a 60% reduction in multi-organ dysfunction.32Scientific Reports. The combination of ulinastatin and somatostatin reduces complication rates in acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials These findings are promising but based largely on studies from a single region, and the drugs are not widely used in Western practice. Larger multinational trials are needed before they become standard care.
Pediatric Considerations
Pancreatitis in children is less common than in adults but is being recognized more frequently. The causes skew differently: gallstones and alcohol are less often to blame, while medications, genetic mutations, and anatomic abnormalities play a larger role. A clinical report from the North American pediatric gastroenterology society recommends that first-time attacks in children should be evaluated with liver enzymes, triglyceride levels, and calcium levels to identify treatable causes.33PubMed Central. The Management of Acute Pancreatitis in the Pediatric Population: A Clinical Report from the NASPGHAN Pancreas Committee When autoimmune pancreatitis is suspected in a child, the workup expands to include immunoglobulin levels and autoantibody profiles to confirm the diagnosis before starting steroids.34BMJ Innovations. Pancreatitis in children: practical management from the BSPGHAN Pancreatitis Working Group The treatment principles, including early feeding, pain management, and addressing the underlying cause, mirror adult practice, but the dosing and thresholds for intervention require pediatric expertise.
Stem Cell Research and Gene Therapy
Looking further ahead, mesenchymal stem cells have shown the ability to reduce pancreatic inflammation in acute pancreatitis and reduce scarring in chronic pancreatitis in animal studies.35PubMed Central. Mesenchymal Stromal Cell Therapy for Pancreatitis: A Systematic Review These cells appear to work primarily by secreting anti-inflammatory molecules rather than by replacing damaged tissue directly.36PubMed. Mesenchymal stem cell therapy for acute and chronic pancreatitis However, substantial variation in cell types, doses, and delivery methods across studies has made it difficult to identify the best approach, and no human clinical trials have yet established stem cell therapy as a viable treatment for pancreatitis.37PubMed Central. Stem cell therapy: a potential for the perils of pancreatitis
Gene therapy is even earlier in its development. Because many forms of chronic and recurrent pancreatitis have identifiable genetic drivers, the concept of correcting or compensating for those mutations at the molecular level is appealing. Current work remains largely at the review and preclinical stage, with researchers mapping out which genetic targets are most promising and what delivery systems could safely reach pancreatic tissue. The gap between this kind of preclinical promise and an actual treatment a patient can receive is wide, likely measured in decades rather than years, but the direction of the research is genuine.